I see that. Google Celebrex... HAHA. That is going to help push this product further. I am just asking to simply find a bases of use, and taking profit share from Celebrex only.
So my thoughts...
If we have pill that combines two pills in one, but the cost is 50% less as one, the cost should be similar to Celebrex(assuming both pills are equal). Just using this example for quick math.
If Celebrex has $1.8B in rev every year, and we take 10% of their market share alone. That leaves us grossing $180M a year. 70% profit margin brings us to $126M per year. Earnings per share (current 3.8M and change) equals around $33. Place a PE of a silly 5 times earnings and we are at $165 per share.. That is when we have FDA approval and sales, that I know. But 10% market share should be less that 3.5 years from now with FDA approval time frame. Especially considering how bad the current Celebrex option is.
What am I missing? Even with dilution, this is a killer deal.
Why wouldn't FDA approve? You have two FDA approved drugs you are slapping together. Is it really going to get denied? People take them together now all the time.
News 
Market Data 
Discover 
AI
